Indian Journal of Drugs in Dermatology

REVIEW ARTICLE
Year
: 2016  |  Volume : 2  |  Issue : 1  |  Page : 3--12

Second-generation antihistamines


Pranjal Anil Mittal, Kiran V Godse, Sharmila P Patil 
 Department of Dermatology, DY Patil School of Medicine, Navi Mumbai, Maharashtra, India

Correspondence Address:
Pranjal Anil Mittal
OPD 54, DY Patil Hospital, Nerul, Navi Mumbai - 400 706, Maharashtra
India

Clinical trials have proved the efficacy of antihistamines in the treatment of chronic idiopathic urticarial (CIU). Second-generation antihistamines are recommended as first-line therapy for CIU. This article reviews the newer second-generation antihistamines in light of recent advances in the understanding of their pharmacology, efficacy, and safety profile. A Google scholar search for second-generation antihistamines was done using the words “second generation H1antihistamines,” “bilastine,” “ebastine,” “olopatadine,” “rupatadine,” “levocetirizine,” “fexofenadine,” “desloratadine,” “histamine,” “allergy,” and “urticaria.” All the articles were retrieved and classified into review articles, studies, double-blinded trials, and case reports. The final data were then analyzed and presented in a narrative fashion.


How to cite this article:
Mittal PA, Godse KV, Patil SP. Second-generation antihistamines.Indian J Drugs Dermatol 2016;2:3-12


How to cite this URL:
Mittal PA, Godse KV, Patil SP. Second-generation antihistamines. Indian J Drugs Dermatol [serial online] 2016 [cited 2024 Mar 28 ];2:3-12
Available from: https://www.ijdd.in/article.asp?issn=2455-3972;year=2016;volume=2;issue=1;spage=3;epage=12;aulast=Mittal;type=0